Moderate to severe periodontitis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with moderate to severe periodontitis referred to the Department of Periodontics Diseases of Kurdistan University of Medical Sciences
Exclusion criteria
Exclusion criteria: The presence of orthodontic brackets, the presence of movable prostheses, any use of sedatives or narcotics by the patient , patient's lack of cooperation , patient's lack of satisfaction. Individuals with gastritis and other digestive problems The patients who using a high dose of Warfarin, Metformin, Methotrexate and Furosemide are excluded from the group receiving Ibuprofen tablets and placed in the group receiving Fluoride gel. Individuals who are allergic to Fluoride gel are excluded from the group receiving Fluoride gel and are placed in the group receiving Ibuprofen tablets or placebo tablets. Patients requiring anesthesia during scaling and root planning due to experiencing severe pain and high levels of anxiety were excluded Patients who using of sedative drugs such as Diazepam, Clonazepam, Triazolam and Alprazolam and other sedative drugs are excluded from the study. Patients consuming sedatives or alcohol that reduces senses are excluded from the study Mothers during pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction amount pain , during the scaling procedure was 1.23% in patients receiving Fluoride gel and in patients receiving a single systemic dose of 400 mg Ibuprofen. Timepoint: 3 months. Method of measurement: Questionnaire VAS (Visual analog scale). | — |
Countries
Iran (Islamic Republic of)
Contacts
Sanandaj University of Medical Sciences